147 related articles for article (PubMed ID: 38615005)
1. The feasibility of half-dose contrast-enhanced scanning of brain tumours at 5.0 T: a preliminary study.
Jiang Z; Sun W; Xu D; Mei H; Yuan J; Song X; Ma C; Xu H
BMC Med Imaging; 2024 Apr; 24(1):88. PubMed ID: 38615005
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
[TBL] [Abstract][Full Text] [Related]
3. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery MRI for intracranial tumors in comparison with post-contrast T1W spin-echo MRI.
Zhou ZR; Shen TZ; Chen XR; Peng WJ
Chin Med J (Engl); 2006 Mar; 119(6):467-73. PubMed ID: 16584644
[TBL] [Abstract][Full Text] [Related]
5. Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI.
Gong E; Pauly JM; Wintermark M; Zaharchuk G
J Magn Reson Imaging; 2018 Aug; 48(2):330-340. PubMed ID: 29437269
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
7. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
8. Brain tumours at 7T MRI compared to 3T--contrast effect after half and full standard contrast agent dose: initial results.
Noebauer-Huhmann IM; Szomolanyi P; Kronnerwetter C; Widhalm G; Weber M; Nemec S; Juras V; Ladd ME; Prayer D; Trattnig S
Eur Radiol; 2015 Jan; 25(1):106-12. PubMed ID: 25194707
[TBL] [Abstract][Full Text] [Related]
9. Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.
DeLano MC; Spampinato MV; Chang EY; Barr RG; Lichtenstein RJ; Colosimo C; Vymazal J; Wen Z; Lin DDM; Kirchin MA; Pirovano G
J Magn Reson Imaging; 2021 Nov; 54(5):1660-1675. PubMed ID: 34018290
[TBL] [Abstract][Full Text] [Related]
10. Brain tumor enhancement in MR imaging at 3 Tesla: comparison of SNR and CNR gain using TSE and GRE techniques.
Wintersperger BJ; Runge VM; Biswas J; Reiser MF; Schoenberg SO
Invest Radiol; 2007 Aug; 42(8):558-63. PubMed ID: 17620938
[TBL] [Abstract][Full Text] [Related]
11. From Dose Reduction to Contrast Maximization: Can Deep Learning Amplify the Impact of Contrast Media on Brain Magnetic Resonance Image Quality? A Reader Study.
Bône A; Ammari S; Menu Y; Balleyguier C; Moulton E; Chouzenoux É; Volk A; Garcia GCTE; Nicolas F; Robert P; Rohé MM; Lassau N
Invest Radiol; 2022 Aug; 57(8):527-535. PubMed ID: 35446300
[TBL] [Abstract][Full Text] [Related]
12. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions.
Al-Saeed O; Ismail M; Athyal RP; Rudwan M; Khafajee S
J Med Imaging Radiat Oncol; 2009 Aug; 53(4):366-72. PubMed ID: 19695043
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of contrast medium use for neuroimaging at 3.0 T: utility of IR-FSE compared to other T1-weighted pulse sequences.
Fischbach F; Bruhn H; Pech M; Neumann F; Ricke J; Felix R; Hoffmann KT
J Comput Assist Tomogr; 2005; 29(4):499-505. PubMed ID: 16012308
[TBL] [Abstract][Full Text] [Related]
14. 3D T1-weighted turbo spin echo contrast-enhanced MRI at 1.5 T for frameless brain metastases radiotherapy.
Yuan J; Law SCK; Wong KK; Lo GG; Kam MKM; Kwan WH; Xue C; Wong OL; Yu SK; Cheung KY
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1749-1759. PubMed ID: 34363123
[TBL] [Abstract][Full Text] [Related]
15. MR susceptibility contrast imaging using a 2D simultaneous multi-slice gradient-echo sequence at 7T.
Bian W; Kerr AB; Tranvinh E; Parivash S; Zahneisen B; Han MH; Lock CB; Goubran M; Zhu K; Rutt BK; Zeineh MM
PLoS One; 2019; 14(7):e0219705. PubMed ID: 31314813
[TBL] [Abstract][Full Text] [Related]
16. Use of half-dose gadolinium-enhanced MRI and magnetization transfer saturation in brain tumors.
Haba D; Pasco Papon A; Tanguy JY; Burtin P; Aube C; Caron-Poitreau C
Eur Radiol; 2001; 11(1):117-22. PubMed ID: 11194902
[TBL] [Abstract][Full Text] [Related]
17. Wave-controlled aliasing in parallel imaging (Wave-CAIPI): Accelerating speed for the MRI-based diagnosis of enhancing intracranial lesions compared to magnetization-prepared gradient echo.
Oh H; Yim Y; Chung MS; Byun JS
PLoS One; 2023; 18(5):e0285089. PubMed ID: 37146026
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of using half-dose Gd-BOPTA for delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) at the knee, compared with standard-dose Gd-DTPA.
Rehnitz C; Do T; Klaan B; Burkholder I; Barié A; Wuennemann F; Kauczor HU; Weber MA
J Magn Reson Imaging; 2020 Jan; 51(1):144-154. PubMed ID: 31141254
[TBL] [Abstract][Full Text] [Related]
19. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced radial 3D fat-suppressed T1-weighted gradient-recalled echo sequence versus conventional fat-suppressed contrast-enhanced T1-weighted studies of the head and neck.
Wu X; Raz E; Block TK; Geppert C; Hagiwara M; Bruno MT; Fatterpekar GM
AJR Am J Roentgenol; 2014 Oct; 203(4):883-9. PubMed ID: 25247956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]